CareyFMenanshiSCrawfordN. Localization of cyclo-oxygenase and thromboxane synthetase in human platelet intracellular membranes. Biochem J1982;204:847–51.
2.
HolmsenHKarpatkinS. Metabolism of platelets. In WilliamsW, Buetler Erslev Lichtman eds Hematology. New York: McGraw Hill, 1983:1136–49.
3.
BerridgeAJIrvineRF. Inositol triphosphate, a novel second messenger in cellular signal transduction. Nature1984;312:315–21.
4.
KaibuchiKTakaiTSawamuraMHosjijimaMFujikuraTNishizukaT. Synergistic functions of protein phosphorylation and calcium mobilization in platelet activation. J Biol Chem1983;258:6701–4.
5.
RittenhouseSE. Lipid alterations in platelet activation. Adv Inflamm Res1984;8:183–201.
6.
PrescottSMMajerusPW. Characterization of 1,2-diacylglycerol hydrolysis in human platelets. Demonstration of an arachidonoyl-monoacyl-glycerat intermediate. J Biol Chem1983;258:764–71.
7.
HolmsenHDanielJLDangelmaierCAMolishIRijmaidenMSmithJB. Differential effects of trifluoperazine on arachindonate liberation, secretion and myosin phosphorylation in intact platelets. Thromb Res1984;36:419–28.
8.
CharoIFFeinmanRDDetwilerTCSmithJBIngermanCMSilverMJ. Prostaglandin endoperoxides and thromboxane A2 can induce platelet aggregation in the absence of secretion. Nature1977;269:66–9.
9.
HungSCGhaliNIVentonDLLeBretonGC. Prostaglandin F2α antagonizes thromboxane A2-induced human platelet aggregation. Prostaglandins1982;24:195–201.
10.
RaoAKWillisJHolmsenH. A major role of ADP in thromboxane transfer experiments: Studies in platelets with secretion defects. J Lab Clin Med1984;104:116–26.
11.
DiMinnoGSilverMJMurphyS. Monitoring the entry of new platelets into circulation after ingestion of aspirin. Blood1983;61:1081–5.
12.
DeGaetanoGCerlettiCBerteleV. Pharmacology of antiplatelet drugs and clinical trials on thrombosis prevention—a difficult link. Lancet1982;2:974–7.
13.
ParryMJ. Effects of thromboxane synthetase inhibition on arachidonate metabolism and platelet behaviour. Br J Clin Pharmacol1983;15:23S–29S.
14.
HeptinstallSFoxSC. Human blood platelet behaviour after inhibition of thromboxane synthetase. Br J Clin Pharmacol1983;15:31S–37S.
15.
LagardeMBurtinMSprecherHDechavanneMRenaudS. Potentiating effect of 5,8,11-eicosatrienoic acid on human platelet aggregation. Lipids1983;18:291–4.
16.
WatanabeTMarimiyaSShimizuTHayashiO. Characterization of the biosynthetic pathway of prostaglandin D2 in human platelet-rich plasma. J Biol Chem1982;257:14847–53.
17.
SmithJB. Effect of thromboxane synthetase inhibitors on platelet function: Enhancement by inhibition of phosphodiesterase. Thromb Res1982;28:477–85.
18.
GreselePDeckmynHHuybrechtsEVermylenJ. Serum albumin enhances the impairment of platelet aggregation with thromboxane synthetase inhibition by increasing the formation of prostaglandin D2. Biochem Pharmacol1984;33:2083–8.
19.
OrchardMAWaddelKALewisPJBlairIA. Thromboxane synthase inhibition causes redirection of prostaglandin endoperoxides to prostaglandin D2 during collagen-stimulated aggregation of human platelet-rich plasma. Thromb Res1985;39:701–10.
20.
LivioMDeImaschioACerlettiCDeGaetanoG. Indomethacine prevents the long-lasting inhibitory effect of aspirin on human platelet cyclooxygenase activity. Prostaglandins1982;23:787–92.
21.
BerteleVFalangaATomasiakMDejanaECerlettiCDeGaetanoG. Platelet thromboxane synthetase inhibitors with low doses of aspirin: Possible resolution of the “aspirin dilemma”. Science1983;220:517–19.
22.
MarcusAJBrekhmanMJWekslerBBJaffeEASafierLBUllmanHLTack-GoldmanK. Interactions between stimulated platelets and endothelial cells in vitro. Phil Trans Royal Soc Lond B1981;294:343–53.
23.
MarcusAJBroekmanMJSafierLKUllmanHLIslamNSernanCNRutherfordLEKorchakHMWeismannG. Formation of leukotrienes and other hydroxy acids during platelet-neutrophil interactions in vitro. Biochem Res Commun1982;109:130–41.
24.
Del MaschioAMacloufJCorvazierEGraugeMJBorgeatP. Activated platelets stimulate human neutrophil functions. Nouv Rev Franc Hemat1985;27:275–8.
25.
DyerbergJ. Platelet-vessel wall interaction: influence of diet. Phil Trans R Soc. Lond B1981;294:373–81.
